Contact

History - Over 100 Years of Continuity

1873

Pharmacist Samuel Benoni Siegfried founds a company with 12 employees to supply pharmacies.

1904

Conversion into a joint stock corporation.

1937

Founding of Ganes Chemical Works, Inc. (NJ, U.S.A.).

1973

Listing on the Swiss Stock Exchange (SWX) in Basel.

1991

Focus on custom manufacturing and development.

2001

Establishment of two core divisions: Siegfried and Sidroga.

2002

Integration of Ganes into the Siegfried Group as Siegfried (U.S.A.) Inc.

2004

Establishment of a representative office in Shanghai, China.

2005

Acquisition of Penick Corporation in New Jersey, U.S.A.

2006

Cooperation agreement with Celgene.

2007

Launch of a pharmaceutical production facility in Malta.
Ramp up of an inhalation technology team in Munich, Germany.
Sale of the Sidroga Division and the biotechnology division.
Cooperation agreement with Arena Pharmaceuticals.

2008

Sale of the pharmaceutical production site at Zofingen to Arena Pharmaceuticals.

2010

Definition of new strategy "Transform".

Implementation of a new function-based organisation.

New investors and capital increase.

Sale of the Munich, Germany subsidiary (Pulmojet project) to
Sanofi-Aventis.

SitemapNewsletterRSS FeedsDisclaimer